Grand Hyatt Hotel, New York City 2012 | November 28-30
Grand Hyatt Hotel, New York City 2012 | November 28-30
Grand Hyatt Hotel, New York City 2012 | November 28-30
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
38<br />
CeCiLia aRRadaza<br />
Director, Communications & Marketing, FasterCures<br />
Cecilia Arradaza is FasterCures’ communications & marketing director. She brings to<br />
FasterCures more than 15 years of experience in public relations, public affairs, and strategic<br />
communications on policy issues that impact medical research and the life sciences<br />
industry. She joined FasterCures from Chandler Chicco Agency (CCA), a pure-play health<br />
communications firm, where she developed public affairs programs for clients including<br />
Johnson & Johnson, the Robert Wood Johnson Foundation, and VHA Inc. Before joining<br />
CCA, Arradaza implemented strategic communications and issues management initiatives<br />
for pharmaceutical and foundation clients of Hyde Park Communications; managed media<br />
relations and public education efforts for the American Psychiatric Association; and was<br />
part of the health and international public affairs practices at Powell Tate. Arradaza began<br />
her health communications career at the National Osteoporosis Foundation and through<br />
an internship with the National Women’s Health Network. She received her bachelor’s<br />
degree from George Washington University at Mount Vernon College.<br />
ChRisTOPheR P. ausTin<br />
Director, National Center for Advancing Translational Sciences<br />
Chris Austin is the director of the National Center for Advancing Translational Sciences<br />
(NCATS) at the National Institutes of Health (NIH). Previously, he was NCATS’ director of<br />
pre-clinical innovation. Prior to that, Austin founded and led the National Center for<br />
Chemical Genomics at NIH, building it into one of the leading centers for high-throughput<br />
screening, chemical probe development, and chemical genomics. He also served as senior<br />
advisor to the director at the National Human Genome Research Institute. Prior to his time<br />
at NIH, Austin spent seven years at Merck, where he directed genomics-based research<br />
programs. He received his bachelor’s degree from Princeton University and his medical<br />
degree from Harvard University.